 In Q4/2018, the Company and its subsidiaries recorded total sales of Baht 1,456 million, a decrease of 5% YoY, mainly due to drop in export CMG, domestic CMG, and domestic branded sales. However

to high domestic ethanol stock, and the increasing aggregate domestic production capacity. Natural Resources Business Group recorded soften performance though the Company still realized additional

1/2 (Translation) Ref. HPIR 004/2018 February 28, 2018 Subject : Management Discussion and Analysis for the year ended December 31, 2017 To : The President The Stock Exchange of Thailand Duplicate

No. B52-202002/001 17 February 2020 Subject: Management Discussion and Analysis - for the year ended 31 December 2019. To: The President of Stock Exchange of Thailand B-52 Capital Public Company

Stock Exchange of Thailand Dear Sir, With reference to the Minutes 11/2017 of the Company Directors’ meeting dated November 13, 2017, the Board resolved to approve the reviewed financial statements of

- Translation - 13 August 2020 Subject: Management’s Discussion and Analysis for the Operating Results of the Second Quarter of 2020 Attention: The President of the Stock Exchange of Thailand Exotic

- Translation - Ref : LPH/SET 2020/012 August 14, 2020 Subject : Clarification on the Operating Results for the 3-month and 6-month period ended June 30, 2020 (Q2/2020) To : President The Stock

www.interpharma.co.th IP_OCS/010/2562 November 10, 2019 Subject Management’s discussion and analysis for the third quarter of 2019 To President The Stock Exchange of Thailand Interpharma Public Company Limited (“the

- Translation - 11 November 2019 Subject: Management’s Discussion and Analysis for the Operating Results of the 3 rd Quarter of 2019 Attention: The President of the Stock Exchange of Thailand Exotic

(the company) and its subsidiaries recorded revenue from sales of goods and rendering of services of THB 125,832 million (+21% YoY), with Net Profit of THB 4,838 million which was net profit attributable